Sodium valproate was administered to Jc1:ICR mice in order to evaluate teratogenicity in the cardiovascular system. A single dose of 600 mg/kg of sodium valproate was injected intraperitoneally on gestational day 6 , 7, 8 or 9. On day 18 of gestation, dams were laparotomized to observe incidence and type of cardiovascular abnormality in live fetuses. Cardiovascular abnormalities were found most frequently in the group treated on day 7 , being recognized in 86% of litters (19/22) and in 29% of live fetuses (70/238). Among these, there were 28 cases of transposition of the great arteries, 13 of double outlet right ventricle, 11 of endocardial cushion defect, 9 of ventricular septa1 defect, 5 of tricuspid atresia, and 4 of hypoplastic left heart syndrome.